Monday, March 25, 2019

New Models and Approaches to Condition Management Leading to Accelerated Growth of Solutions

New Chilmark Research report assesses maturity of solution features, sets forth rationale for rapid growth. Key healthcare stakeholders are accelerating the adoption of more personalized and holistic approaches to chronic condition management, driven by...

Autologous Stem Cell Therapy May Hold Key to Regeneration

USRM Chief Science Officer's Live Webinar Adds Voice to Debate U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the...

GCE Launches Groundbreaking New Product: Shadow

GCE Solutions, a global clinical research organization (CRO), announces the launch of Shadow, a powerful new data and document anonymization solution on October 4, 2017. Shadow is designed to assist medical writers and biometrics...

Enhanced Healthcare Partners Announces Investment in SCA Pharmaceuticals

Enhanced Healthcare Partners ("EHP"), a private equity firm focused exclusively on investing in the healthcare industry, has announced its investment in SCA Pharmaceuticals ("SCA"), a sterile compounding leader specializing in preparing sterile pharmaceuticals...

FDA approves Mylotarg for treatment of acute myeloid leukemia

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also...

Mitra Biotech Partners with Gotect Diagnostic in Israel

Mitra Biotech, a global leader in advancing the personalization of cancer treatment, today announced an agreement with Gotect Diagnostic for the exclusive right to represent Mitra in Israel. Mitra's CANscript™ platform recreates a patient's own...

EDGC to Launch Liquid Biopsy Screening Service, Technology for Early Detection of Cancers, This...

Liquid biopsy drawing attention for preventing the recurrence of cancer and allowing for early detection of cancers EDGC develops the most advanced lipuid biopsy technology EONE-DIAGNOMICS Genome Center (EDGC), a global company in genetic analysis, has announced the...

Mylan Launches First AP-rated Generic Avelox® Injection

Mylan N.V. today announced the U.S. launch of Moxifloxacin Hydrochloride in 0.8% Sodium Chloride Injection, 400 mg/250 mL (1.6 mg/mL) in 250 mL single-dose flexible bags, the first AP-rated generic version of Bayer's...

Revolutionary Erectile Dysfunction Treatment, GAINSWave®, Now Offered by Havkin Urology in Florida

Havkin Urology is implementing a non-invasive and drug free solution for Erectile Dysfunction (ED) called GAINSWave, which boasts a 75% success rate. GAINSWave is a premium brand of shockwave therapy designed to remove micro-plaque and stimulate...

RWS Expands Global Offering with RWS Life Sciences

The acquisition of LUZ, Inc. and Corporate Translations, Inc. strengthens RWS' market leadership and continued growth of life science language services On October 1, 2017 RWS, the world's leading provider of translation, intellectual property, life sciences...

Connect with us

4,514FansLike
1,007FollowersFollow
12,053FollowersFollow

Popular Posts